Preclinical assessment of an anti-HTLV-1 heterologous DNA/MVA vaccine protocol expressing a multiepitope HBZ protein.

D S O Daian E Silva L J Cox A S Rocha Á Lopes-Ribeiro J P C Souza G M Franco J L C Prado Thaiza Aline Pereira-Santos Marina Lobato Martins Jordana Grazziela Alves Coelho-Dos-ReisT M Gomes-de-PinhoFlavio Guimarães da Fonseca Edel Figueiredo Barbosa-Stancioli

Published in: Virology journal (2023)

Our results highlight the potential of the HBZ multiepitope protein expressed from plasmid DNA and a poxviral vector as candidates for therapeutic vaccine.

Keyphrases

circulating tumor
cell free
single molecule
protein protein
escherichia coli
randomized controlled trial
amino acid
binding protein
crispr cas
nucleic acid
small molecule
circulating tumor cells
saccharomyces cerevisiae